Influence of [<sup>18</sup>F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study

Influence of [<sup>18</sup>F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study

There is a lack of evidence regarding the clinical impact of [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomography ([<sup>18</sup>F]FDG-PET/CT, hereinafter referred to as PET/CT), especially regarding management changes and their link to overall...

Full description

Bibliographic Details
Main Authors: Sebastian Werner, Julia Sekler, Brigitte Gückel, Christian la Fougère, Konstantin Nikolaou, Christina Pfannenberg, Heike Preibsch, Tobias Engler, Susann-Cathrin Olthof
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Diagnostics
Subjects:
breast neoplasms
positron emission tomography computed tomography
fluorodeoxyglucose F18
survival rate
registries
Online Access:https://www.mdpi.com/2075-4418/13/14/2420

Internet

https://www.mdpi.com/2075-4418/13/14/2420

Similar Items